Brain Liquid Biopsy Assay
Creative Biolabs is at the forefront of scientific innovation, continuously striving to develop groundbreaking technologies that advance the field of neuroscience. Our latest cutting-edge service, the Brain Liquid Biopsy Assay, has revolutionized the field of neurological diagnostics. By harnessing the power of circulating tumor cells (CTCs) analysis, brain-derived exosomes analysis, and cfDNA analysis, our Brain Liquid Biopsy Assay service offers unparalleled insights into the complex workings of the brain and opens new avenues for diagnosis, monitoring, and treatment of neurological disorders.
Our Technology
At Creative Biolabs, we have developed a state-of-the-art platform that combines multiple cutting-edge technologies to enable comprehensive analysis of brain-derived biomarkers. By combining these approaches, our assay provides comprehensive insights into the neurological landscape of patients, leading to more accurate diagnoses and improved patient outcomes.
-
Circulating Tumor Cells (CTCs) Analysis
CTCs are rare cells shed by primary brain tumors into the bloodstream. The analysis of CTCs provides valuable information on tumor heterogeneity, enabling personalized treatment strategies and monitoring of treatment efficacy. Once captured and concentrated, these circulating tumor cells (CTCs) can be examined, offering insights into the current state of a disease. Importantly, our liquid biopsy technique is far less invasive for patients compared to the conventional surgical biopsy. -
cfDNA & cfRNA Analysis
Cell-free DNA (cfDNA) refers to the small fragments of DNA that circulate freely in the bloodstream. Our Brain Liquid Biopsy Assay includes the analysis of cfDNA derived from the brain, providing insights into various neurological conditions. By detecting specific genetic alterations, such as mutations or epigenetic modifications, cfDNA analysis can aid in the diagnosis and monitoring of brain tumors, neurodegenerative diseases, and psychiatric disorders. -
Brain-Derived Exosomes Analysis
Exosomes are small vesicles released by cells that contain a wealth of information about their molecular composition. In the context of the brain, brain-derived exosomes (neuronal, astrocyte, and oligodendrocyte origin) offer a unique window into the neurological landscape. Our Brain Liquid Biopsy Assay leverages advanced techniques to isolate and analyze these exosomes, enabling the identification of specific biomarkers associated with neurological disorders, such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis. This analysis can facilitate early detection, disease progression monitoring, and the development of targeted therapies.
Fig.1 CTCs capture, enrichment, and characterization.1
Fig.2 Liquid biopsy in brain tumor.2
Fig.3 Brain-originated exosomes (neuronal, astrocytic, and oligodendrocytic origin). 3
Highlight

Multi-platform Analysis
These platform technologies may include advanced molecular biology techniques, high-throughput sequencing, next-generation sequencing (NGS), single-cell analysis, and various other cutting-edge methodologies.

Customizability
We offer customized assay design services tailored to meet specific requirements. Our team of experienced scientists collaborates closely with clients to develop assays that target specific biomarkers, optimize sensitivity, and ensure reliable and reproducible results.

Precision
By maintaining strict protocols and standardized procedures, precision ensures that sample analysis data remains consistent and reliable, providing confidence in the results obtained from various locations worldwide.
Please contact us today to explore the potential for collaboration with our organization.
References
- Yang, Chaogang, et al. "Circulating tumor cells in gastrointestinal cancers: current status and future perspectives." Frontiers in oncology 9 (2019): 1427.
- Eibl, Robert H., and Markus Schneemann. "Liquid biopsy and primary brain tumors." Cancers 13.21 (2021): 5429.
- iNeuMab™ Anti-GD2 Antibody (NRZP-1222-ZP767) (Cat#: NRZP-1222-ZP767)
- iNeuMab™ Anti-GARP Antibody (NRP-0422-P1639) (Cat#: NRP-0422-P1639)
- iNeuMab™ Anti-ApoC3 BBB Shuttle Antibody (NRZP-1022-ZP3505) (Cat#: NRZP-1022-ZP3505)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- iNeuMab™ Anti-CD20 Antibody (NRP-0422-P1230) (Cat#: NRP-0422-P1230)
- iNeuMab™ Anti-pTau Antibody (NRP-0422-P1719) (Cat#: NRP-0422-P1719)
- iNeuMab™ Anti-Alpha Synuclein Antibody (NRP-0422-P614) (Cat#: NRP-0422-P614)
- iNeuMab™ Anti-SEZ6 Antibody (NRP-0422-P517) (Cat#: NRP-0422-P517)
- iNeuMab™ Anti-Alpha Synuclein BBB Shuttle Antibody (NRZP-1022-ZP4050) (Cat#: NRZP-1022-ZP4050)
- iNeuMab™ Anti-CD32b Antibody (NRP-0422-P1803) (Cat#: NRP-0422-P1803)
- iNeu™ Human Schwann Cell (Cat#: NCL-2103-P63)
- Human Astrocytes, Immortalized (Cat#: NCL-2105-P182-AM)
- Rat Muller Cell (Cat#: NCL2110P040)
- Rat Glioma Cell Line C6 (Cat#: NCL2110P346)
- Green Fluorescent Tau cell Line (Cat#: NCL2110P219)
- Rat Retinal Muller Cell Line, Immortalized (Cat#: NCL-21P6-192)
- Immortalized Human Cerebral Microvascular Endothelial Cells (Cat#: NCL-2108-P020)
- Mouse Microglia N9 (Cat#: NCL2110P073)
- Human Dental Pulp Stem Cells (Cat#: NRZP-1122-ZP113)
- Human Glial (Oligodendrocytic) Hybrid Cell Line (MO3.13) (Cat#: NCL-2108P34)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)